FDA wins high-profile support in consumer genetics kerfuffle

annas11-150x150Los Angeles Times
George Annas, School of Public Health

When the Food & Drug Administration last November ordered the Mountain View, Calif.-based firm 23andMe to stop marketing its genetic test kit to consumers, the ensuing debate took on a “rage against the machine” tenor…

Expert quote:

“The FDA was right to issue a warning to 23andMe.”

View full article